Suppr超能文献

中段胆管癌:胆管节段切除术是否合适?

Carcinoma of the middle bile duct: is bile duct segmental resection appropriate?

机构信息

Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 135-710, South Korea.

出版信息

World J Gastroenterol. 2009 Dec 21;15(47):5966-71. doi: 10.3748/wjg.15.5966.

Abstract

AIM

To compare survival between bile duct segmental resection (BDSR) and pancreaticoduodenectomy (PD) for treating distal bile duct cancers.

METHODS

Retrospective analysis was conducted for 45 patients in a BDSR group and for 149 patients in a PD group.

RESULTS

The T-stage (P < 0.001), lymph node invasion (P = 0.010) and tumor differentiation (P = 0.005) were significant prognostic factors in the BDSR group. The 3- and 5-year overall survival rates for the BDSR group and PD group were 51.7% and 36.6%, respectively and 46.0% and 38.1%, respectively (P = 0.099). The BDSR group and PD group did not show any significant difference in survival when this was adjusted for the TNM stage. The 3- and 5-year survival rates were: stage Ia [BDSR (100.0% and 100.0%) vs PD (76.9% and 68.4%) (P = 0.226)]; stage Ib [BDSR (55.8% and 32.6%) vs PD (59.3% and 59.3%) (P = 0.942)]; stage IIb [BDSR (19.2% and 19.2%) vs PD (31.9% and 14.2%) (P = 0.669)].

CONCLUSION

BDSR can be justified as an alternative radical operation for patients with middle bile duct in selected patients with no adjacent organ invasion and resection margin is negative.

摘要

目的

比较胆管节段切除术(BDSR)和胰十二指肠切除术(PD)治疗远端胆管癌的生存情况。

方法

回顾性分析 45 例 BDSR 组和 149 例 PD 组患者。

结果

BDSR 组的 T 分期(P<0.001)、淋巴结侵犯(P=0.010)和肿瘤分化(P=0.005)是显著的预后因素。BDSR 组和 PD 组的 3 年和 5 年总生存率分别为 51.7%和 36.6%,46.0%和 38.1%(P=0.099)。当按 TNM 分期调整时,BDSR 组和 PD 组的生存无显著差异。3 年和 5 年生存率为:Ia 期[BDSR(100.0%和 100.0%)vs PD(76.9%和 68.4%)(P=0.226)];Ib 期[BDSR(55.8%和 32.6%)vs PD(59.3%和 59.3%)(P=0.942)];IIb 期[BDSR(19.2%和 19.2%)vs PD(31.9%和 14.2%)(P=0.669)]。

结论

BDSR 可作为一种选择性根治性手术方法,适用于无邻近器官侵犯且切缘阴性的中胆管癌患者。

相似文献

1
Carcinoma of the middle bile duct: is bile duct segmental resection appropriate?
World J Gastroenterol. 2009 Dec 21;15(47):5966-71. doi: 10.3748/wjg.15.5966.
3
Prognostic factors in patients with middle and distal bile duct cancers.
World J Gastroenterol. 2014 Jun 7;20(21):6658-65. doi: 10.3748/wjg.v20.i21.6658.
4
Prognostic Factors for Distal Bile Duct Carcinoma After Surgery.
Kurume Med J. 2023 Jul 3;68(2):81-89. doi: 10.2739/kurumemedj.MS682002. Epub 2023 Mar 31.
5
Benefits and limitations of middle bile duct segmental resection for extrahepatic cholangiocarcinoma.
Hepatobiliary Pancreat Dis Int. 2020 Apr;19(2):147-152. doi: 10.1016/j.hbpd.2020.01.002. Epub 2020 Jan 30.
7
Is Pancreaticoduodenectomy Feasible for Recurrent Remnant Bile Duct Cancer Following Bile Duct Segmental Resection?
J Gastrointest Surg. 2015 Dec;19(12):2138-45. doi: 10.1007/s11605-015-2927-8. Epub 2015 Sep 4.
9
Carcinoma of the distal and middle bile duct: surgical results, prognostic factors, and long-term follow-up.
J Hepatobiliary Pancreat Surg. 2008;15(5):501-7. doi: 10.1007/s00534-007-1308-4. Epub 2008 Oct 4.
10
Treatment of mid-bile duct carcinoma: Local resection or pancreatoduodenectomy?
Eur J Surg Oncol. 2019 Nov;45(11):2180-2187. doi: 10.1016/j.ejso.2019.06.032. Epub 2019 Jun 29.

引用本文的文献

1
Cholangiocarcinoma of the Middle Bile Duct: A Narrative Review.
Ann Surg Oncol. 2024 Oct;31(10):6504-6513. doi: 10.1245/s10434-024-15567-4. Epub 2024 Jul 7.
3
Intraductal papillary neoplasm of the bile duct with metachronous development in the downstream bile duct after radical resection.
Clin J Gastroenterol. 2024 Feb;17(1):155-163. doi: 10.1007/s12328-023-01867-x. Epub 2023 Oct 14.
7
Comparison of the clinical results of surgical resection for extrahepatic cholangiocarcinomas: Hilar cholangiocarcinoma and mid-to-distal cholangiocarcinoma.
Ann Hepatobiliary Pancreat Surg. 2019 Nov;23(4):319-326. doi: 10.14701/ahbps.2019.23.4.319. Epub 2019 Nov 29.
9
Bile duct segmental resection versus pancreatoduodenectomy for middle and distal common bile duct cancer.
Ann Surg Treat Res. 2018 May;94(5):240-246. doi: 10.4174/astr.2018.94.5.240. Epub 2018 Apr 30.
10
The Likely Sites of Nodal Metastasis Differs According to the Tumor Extent in Distal Bile Duct Cancer.
J Gastrointest Surg. 2016 Sep;20(9):1618-27. doi: 10.1007/s11605-016-3179-y. Epub 2016 Jun 2.

本文引用的文献

3
Actual long-term outcome of extrahepatic bile duct cancer after surgical resection.
Ann Surg. 2005 Jan;241(1):77-84. doi: 10.1097/01.sla.0000150166.94732.88.
6
Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma.
Ann Surg. 2001 Oct;234(4):507-17; discussion 517-9. doi: 10.1097/00000658-200110000-00010.
7
Prognostic significance of lymph node involvement in middle and distal bile duct cancer.
Surgery. 2001 Jun;129(6):677-83. doi: 10.1067/msy.2001.114555.
8
Treatment strategy for patients with middle and lower third bile duct cancer.
Br J Surg. 2001 Mar;88(3):364-70. doi: 10.1046/j.1365-2168.2001.01685.x.
9
Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience.
J Hepatobiliary Pancreat Surg. 2000;7(2):155-62. doi: 10.1007/s005340050170.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验